JP2025507820A5 - - Google Patents

Info

Publication number
JP2025507820A5
JP2025507820A5 JP2024551891A JP2024551891A JP2025507820A5 JP 2025507820 A5 JP2025507820 A5 JP 2025507820A5 JP 2024551891 A JP2024551891 A JP 2024551891A JP 2024551891 A JP2024551891 A JP 2024551891A JP 2025507820 A5 JP2025507820 A5 JP 2025507820A5
Authority
JP
Japan
Prior art keywords
alkyl
ring
independently
compound according
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024551891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507820A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/063623 external-priority patent/WO2023168367A1/en
Publication of JP2025507820A publication Critical patent/JP2025507820A/ja
Publication of JP2025507820A5 publication Critical patent/JP2025507820A5/ja
Pending legal-status Critical Current

Links

JP2024551891A 2022-03-02 2023-03-02 キノリンcGasアンタゴニスト化合物 Pending JP2025507820A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263315968P 2022-03-02 2022-03-02
US63/315,968 2022-03-02
US202363478467P 2023-01-04 2023-01-04
US63/478,467 2023-01-04
PCT/US2023/063623 WO2023168367A1 (en) 2022-03-02 2023-03-02 QUINOLINE cGAS ANTAGONIST COMPOUNDS

Publications (2)

Publication Number Publication Date
JP2025507820A JP2025507820A (ja) 2025-03-21
JP2025507820A5 true JP2025507820A5 (https=) 2026-03-10

Family

ID=85781707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024551891A Pending JP2025507820A (ja) 2022-03-02 2023-03-02 キノリンcGasアンタゴニスト化合物

Country Status (11)

Country Link
US (3) US12281078B2 (https=)
EP (1) EP4486734A1 (https=)
JP (1) JP2025507820A (https=)
KR (1) KR20250004639A (https=)
CN (1) CN119137112A (https=)
AU (1) AU2023228915A1 (https=)
CA (1) CA3253386A1 (https=)
IL (1) IL315346A (https=)
MX (1) MX2024010674A (https=)
TW (1) TW202342021A (https=)
WO (1) WO2023168367A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230062845A (ko) 2020-09-03 2023-05-09 이뮨센서 테라퓨틱스, 인코포레이티드 퀴놀린 cgas 길항제 화합물
IL315346A (en) 2022-03-02 2024-11-01 Immunesensor Therapeutics Inc CGAS agonistic quinoline compounds
US20260092048A1 (en) 2024-08-30 2026-04-02 Immunesensor Therapeutics, Inc. Solid forms and salts of a quinoline cgas antagonist compound
WO2026057087A1 (zh) * 2024-09-14 2026-03-19 杭州英创医药科技有限公司 作为cGAS抑制剂的化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542785A (en) * 1967-05-15 1970-11-24 Ciba Geigy Corp 2-hydroxy-4-aryl-quinolines
US3668207A (en) * 1970-01-22 1972-06-06 Ciba Geigy Corp 2-amino-4-aryl-quinolines
BR0312204A (pt) * 2002-06-27 2005-04-26 Schering Ag Antagonista de receptor ccr5 de quinolina substituìda
CA2699697A1 (en) 2007-09-27 2009-04-02 F. Hoffmann-La Roche Ag Quinoline derivatives as 5ht5a receptor antagonists
US20190127354A1 (en) * 2015-12-14 2019-05-02 Fundación Para La Investigación Médica Aplicada 2,4,6,7-tetrasubstituted quinoline compounds as inhibitors of dna methyltransferases
CN109111426B (zh) 2017-06-23 2021-12-14 中国科学院上海药物研究所 一类稠合双环杂芳基或芳基化合物,及其用途
KR20240151869A (ko) 2017-09-08 2024-10-18 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Enpp1 저해제 및 암의 치료용의 이의 용도
WO2019241787A1 (en) 2018-06-15 2019-12-19 The Regents Of The University Of Colorado A Body Corporate Novel cyclic gmp-amp synthase (cgas) inhibitors and their method of use
PL3829581T3 (pl) 2018-07-27 2024-07-01 Arcus Biosciences, Inc. Antagoniści pirydonu a2r
EP3620164A1 (en) * 2018-09-05 2020-03-11 Genoscience Pharma SAS Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins b (ctsb), l (ctsl) and d (ctsd) related diseases
CA3125626A1 (en) 2019-01-04 2020-07-09 Bellbrook Labs, Llc Inhibitors of cgas activity as therapeutic agents
CA3164995A1 (en) 2019-12-20 2021-06-24 Erasca, Inc. Tricyclic pyridones and pyrimidones
AU2021211437A1 (en) 2020-01-20 2022-09-15 Crescenta Biosciences Novel cell metabolism modulating compounds and uses thereof
WO2022010948A1 (en) 2020-07-06 2022-01-13 Crescenta Biosciences Novel cell metabolism modulating compounds and uses thereof for the treatment of viral diseases
KR20230062845A (ko) 2020-09-03 2023-05-09 이뮨센서 테라퓨틱스, 인코포레이티드 퀴놀린 cgas 길항제 화합물
IL315346A (en) 2022-03-02 2024-11-01 Immunesensor Therapeutics Inc CGAS agonistic quinoline compounds

Similar Documents

Publication Publication Date Title
JP2025507820A5 (https=)
KR102516038B1 (ko) cGAS 길항제 화합물
JP6663857B2 (ja) ピラゾロピリジンおよびピラゾロピリミジン
AU2021336977A1 (en) Quinoline cGAS antagonist compounds
ES2589801T3 (es) Derivados de dihidroquinolina como inhibidores de bromodominio
CN113683614B (zh) 用于治疗正粘病毒感染的稠合三环哒嗪酮化合物
JP2025507820A (ja) キノリンcGasアンタゴニスト化合物
US20230126473A1 (en) Phosphorus imidazoquinoline amine derivatives, pharmaceutical compositions and therapeutic methods thereof
CN110407854B (zh) 新的四环化合物
CN115703738A (zh) 含2-芳杂环取代的脲类化合物、其制备方法和用途
HK40120448A (zh) 喹啉cgas拮抗剂化合物
HK40094674A (zh) 喹啉cgas拮抗剂化合物
US20260049084A1 (en) Enpp1 modulators and products and uses thereof
HK40113325A (zh) 作为正粘病毒复制抑制剂用於治疗流感的化合物
HK40063819B (zh) Tyk2抑制剂和其用途
HK40066535B (zh) 磷咪唑并喹啉胺衍生物、及其药物组合物和应用
HK40066535A (zh) 磷咪唑并喹啉胺衍生物、及其药物组合物和应用
HK40033744B (zh) 作为正粘病毒复制抑制剂用於治疗流感的化合物
HK40009791B (zh) 用於治疗正粘病毒感染的稠合三环哒嗪酮化合物
HK40004439B (zh) Cgas拮抗剂化合物
HK1234392A1 (en) Pyrazolopyridines and pyrazolopyrimidines
HK40004439A (en) Cgas antagonist compounds